Acetaminophen is one of the most common analgesics and antipyretics (fever reducers) available over the counter. It is generally regarded as safe. However, it is also the most common cause of toxic hepatitis in North America and Europe and one of the most common poisonings from either accidental or intentional overdose.
Acetaminophen monitoring can determine if an overdose has occurred and if an antidote is required; to assess the risk of liver damage and to help monitor the outcome of antidote treatment.
Randox Toxicology have developed a new acetaminophen single-plex biochip assay which is available on the Evidence MultiSTAT, to aid in the monitoring of acetaminophen at the location of treatment.
Benefits
Quick and Accurate Results
Rapid results in <25 minutes facilitate early toxicity detection, reducing acute liver failure and transplant needs.
Early Antidote Intervention
Real-time data helps clinicians quickly determine whether the
antidote N-acetylcysteine (NAC) is needed within the critical 8-hour window.
Flexible Sample Types
Clinicians can use serum or plasma samples based on availability, reducing delays and improving patient care.
Test Patients as Needed
No batch processing allows on-demand testing, reducing wastage and wait times for results
Improved Patient Outcomes
Fast analysis at the location of treatment allows for timely clinical decisions and better patient management.
No Advanced Skills Required
Minimal sample preparation and machine functionality reduce the need for specialised training.
